USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 8, 13:41 PM 2012

NYSE 8065.40 4.31 Index Moved Down

NASDAQ 2907.76 3.68 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for SLXP and USNA...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Salix Pharmaceuticals Ltd. and

USANA Health Sciences Inc. Com

Volatility

Matrix

Run Correlation

Diversification

Significant diversification

Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and USANA Health Sciences Inc. Com in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.08

Parameters

Time Period	1 Month [change]
Direction	Positive
Strength	Insignificant
Accuracy	95.65%
Values	Daily Returns

Suggest

Salix Pharmaceuticals Ltd.

Profile

48.78

Intraday

One Month

^0.35

0.72%

SLXP

NASDAQ

Salix Pharmaceuticals Ltd.

P/E	37.25	Day Low	48.33
Open	48.74	P/B Ratio	5.96
Market Cap	2.885B	Volume	206377
Sector	Healthcare	Last Close	48.43
Short Ratio	7.80	Last Traded	2/8/2012
Year High	50.28	Percent Change	0.72%
EBITDA	142.7M	Year Low	25.64
Absolute Change	0.35	Time	Not Applicable
Book Value	8.127	EPS	1.30
PEG Ratio	0.93	Employees	390
Day High	49.09	Industry	Drugs - Generic
Target Price	54.53	Current EPS	1.30
This Year EPS	2.53	Next Year EPS	2.78
Current PE	37.25	This Year PE	19.14
Next Year PE	17.42	Dividend	Not Applicable

USANA Health Sciences Inc. Comm

Profile

36.59

Intraday

One Month

^0.77

2.15%

USNA

NYSE

USANA Health Sciences Inc. Com

P/E	11.42	Day Low	34.90
Open	35.00	P/B Ratio	3.37
Market Cap	547.3M	Volume	90040
Sector	Healthcare	Last Close	35.82
Short Ratio	33.90	Last Traded	2/8/2012
Year High	38.50	Percent Change	2.15%
EBITDA	84.0M	Year Low	23.10
Absolute Change	0.77	Time	Not Applicable
Book Value	10.642	EPS	3.137
PEG Ratio	0.57	Employees	1,240
Day High	36.60	Industry	Drug Related Product
Target Price	37.40	Current EPS	3.137
This Year EPS	3.52	Next Year EPS	4.07
Current PE	11.42	This Year PE	10.18
Next Year PE	8.80	Dividend	Not Applicable